Global circumferential left ventricular strain impairment in hypertrophic cardiomyopathy: comparison to left ventricular hypertrophy and late gadolinium enhancement
Laurent Macron(Clinique Hartmann), Élie Mousseaux(MACOM (United States)), Alban Redheuil(Sorbonne Université), Golmehr Ashrafpoor(Université Paris Cité), Patrick Clarysse(Université Claude Bernard Lyon 1), Albert Hagège, Émilie Bollache(Centre National de la Recherche Scientifique), Michel Desnos(Hôpital Européen Georges-Pompidou), Pierre Croisille(Centre National de la Recherche Scientifique), Nadjia Kachenoura(Inserm)
Cited by 3
Related Papers
Mavacamten for treatment of symptomatic obstructive hypertrophic cardiomyopathy (EXPLORER-HCM): a randomised, double-blind, placebo-controlled, phase 3 trial
|The Lancet|2020|1.2k
Sports-Related Sudden Death in the General Population
|Circulation|2011|541
Mitral valve disease—morphology and mechanisms
|Nature Reviews Cardiology|2015|387
Computed Tomography Aortic Valve Calcium Scoring in Patients With Aortic Stenosis
|Circulation Cardiovascular Imaging|2018|384
Clinical Profile, Contemporary Management and One-Year Mortality in Patients with Severe Acute Heart Failure Syndromes: The EFICA Study
|European Journal of Heart Failure|2006|351